Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

556
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
556
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

2.3K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
2.3K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

4.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

352
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
352
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

486
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
486

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased mortality.

ESC heart failure·2026
Same author

Functional evaluation of TRPC6 missense variants in cancer patients via molecular docking analysis compared with patch Clamp electrophysiology.

The Journal of biological chemistry·2026
Same author

Prognostic value of multi-marker stress echocardiography.

Future cardiology·2026
Same author

Moderate-dose doxorubicin does not affect right ventricular size or function parameters in lymphoma patients-a single-center study.

European heart journal open·2026
Same author

Functional Evaluation of <i>TRPC6</i> Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology.

bioRxiv : the preprint server for biology·2026
Same author

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies <i>MMP16</i> and <i>KCTD15</i> as risk loci.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Mar 5, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

Rationale for Cardio-Oncology Units.

Lara F Nhola1, Hector R Villarraga1

  • 1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Revista Espanola De Cardiologia (English Ed.)
|March 24, 2017
PubMed
Summary
This summary is machine-generated.

Cardio-oncology addresses the cardiovascular needs of cancer patients and survivors. This specialty manages treatment side effects and improves patient outcomes through collaborative care.

Keywords:
Cancer patientsCancer survivalCardio-oncology unitsCardiotoxicidadCardiotoxicityPaciente con cáncerSuperviviente al cáncerUnidades de cardio-oncología

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.6K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

Related Experiment Videos

Last Updated: Mar 5, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.6K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

Area of Science:

  • Cardiology
  • Oncology
  • Cardio-oncology

Background:

  • Increasing number of cancer survivors with cardiovascular disease.
  • Need for specialized care for cancer patients with heart conditions.
  • Awareness of cardiovascular toxicity from cancer therapies is crucial.

Purpose of the Study:

  • Outline the impact of cancer therapies on cardiovascular health.
  • Highlight the benefits of a multidisciplinary team approach.
  • Describe clinical care delivery for patients with cancer and heart disease.

Main Methods:

  • Review of current literature on cardio-oncology.
  • Discussion of collaborative care models.
  • Analysis of cardiovascular complications from cancer treatments.

Main Results:

  • Cancer therapies significantly impact cardiovascular health.
  • Multidisciplinary teams improve management of cardiovascular complications.
  • Specialized cardio-oncology care is essential for optimal outcomes.

Conclusions:

  • Cardio-oncology bridges cardiology and oncology.
  • Collaboration is key to mitigating cardiovascular toxicity.
  • A comprehensive plan improves care for cancer patients with heart disease.